Trevi Therapeutics's total assets for Q3 2025 were $199.36M, a decrease of ― from the previous quarter. TRVI total liabilities were $9.57M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.